TRAG-3 Inhibitors
Chemical inhibitors of TRAG-3 function through various mechanisms to impede the protein's role in cell cycle regulation and DNA synthesis. Methotrexate, for instance, undermines the activity of dihydrofolate reductase, an enzyme vital for nucleotide synthesis, thereby curbing the DNA replication capacity that TRAG-3 relies on. Analogously, camptothecin targets topoisomerase I, essential for DNA replication and cell division, disrupting the cell cycle and thus the context in which TRAG-3 operates. Paclitaxel and vincristine both disrupt microtubule dynamics, which are crucial for mitotic spindle formation and cell division. By stabilizing microtubules and preventing their assembly, respectively, these compounds impair cell division, undermining TRAG-3's function in proliferating cells. Etoposide and doxorubicin both impede topoisomerase II, halting DNA replication and repair processes, which are fundamental to TRAG-3's role in cell proliferation.
Further, cyclophosphamide and cisplatin both induce DNA crosslinks, obstructing DNA replication and transcription, thereby indirectly inhibiting TRAG-3 activity. Bleomycin introduces DNA strand breaks, thwarting DNA synthesis and consequently, TRAG-3 activity. Bortezomib, through proteasome inhibition, disrupts cellular protein homeostasis and signaling pathways, which may decrease TRAG-3 activity as it depends on regulated protein turnover for cell cycle progression. Hydroxyurea impedes ribonucleotide reductase, reducing deoxyribonucleotide pools and thus DNA replication, crucial for TRAG-3 function. Lastly, gemcitabine, a nucleoside analog, incorporates into DNA and halts the replication fork, blocking the DNA replication that is essential for TRAG-3's role in cell cycle progression. Each of these chemicals, by targeting specific cellular processes, can interfere with the functioning of TRAG-3 within the intricate framework of cell proliferation and DNA replication.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate is known to inhibit the enzyme dihydrofolate reductase, which is critical in the thymidylate synthesis pathway. TRAG-3 is implicated in cell cycle regulation and DNA synthesis. Therefore, inhibiting a key enzyme in nucleotide synthesis can result in the reduction of TRAG-3 activity due to decreased DNA replication capacity. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin targets topoisomerase I, which is essential for DNA replication and cell division. As TRAG-3 is associated with rapidly dividing cells, the inhibition of DNA replication by camptothecin can lead to the functional inhibition of TRAG-3 due to the disruption of the cell cycle in which TRAG-3 operates. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and as a consequence, disrupts the mitotic spindle formation. Since TRAG-3 is involved in cell proliferation, inhibiting spindle assembly can impair cell division, thereby functionally inhibiting the action of TRAG-3 by preventing cells from progressing through mitosis. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits topoisomerase II, an enzyme involved in DNA replication and cell cycle progression. The inhibition of this enzyme can result in the functional inhibition of TRAG-3 as it impedes the cell cycle and DNA replication processes in which TRAG-3 is involved. | ||||||
Cyclophosphamide | 50-18-0 | sc-361165 sc-361165A sc-361165B sc-361165C | 50 mg 100 mg 500 mg 1 g | $90.00 $146.00 $469.00 $791.00 | 18 | |
Cyclophosphamide forms DNA crosslinks, preventing DNA replication and transcription. This mechanism can lead to the functional inhibition of TRAG-3 since it is involved in cell cycle control and proliferation, and its activity is closely linked to DNA replication fidelity and cellular division. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin forms DNA adducts and crosslinks, which can inhibit DNA replication and transcription. This mode of action may lead to the functional inhibition of TRAG-3 by preventing the cell cycle progression and DNA replication processes that are necessary for TRAG-3's role in cell proliferation. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Bleomycin causes DNA strand breaks, which can inhibit DNA synthesis and transcription. By inducing DNA damage and disrupting replication, bleomycin can functionally inhibit TRAG-3 activity as it relies on intact DNA replication mechanisms to perform its role in cell cycle progression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib inhibits the 26S proteasome, leading to the accumulation of proteins that are normally degraded. This proteasome inhibition can disrupt various cell signaling pathways, potentially leading to a reduction in TRAG-3 activity, which is dependent on tightly regulated protein turnover and cell cycle progression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, which is essential for DNA synthesis. The inhibition of this enzyme can lead to a decrease in deoxyribonucleotide pools, thus impairing DNA replication. This can functionally inhibit TRAG-3, which is associated with DNA replication and cell cycle progression. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Gemcitabine is a nucleoside analog that gets incorporated into DNA, leading to chain termination during DNA replication. This can inhibit processes in which TRAG-3 is involved, particularly cell proliferation and cycle progression, by blocking the replication fork progression. | ||||||